Utah Medical Products (UTMD) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $128.0 million.
- Utah Medical Products' Retained Earnings fell 454.67% to $128.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.0 million, marking a year-over-year decrease of 454.67%. This contributed to the annual value of $129.3 million for FY2024, which is 653.39% down from last year.
- Utah Medical Products' Retained Earnings amounted to $128.0 million in Q3 2025, which was down 454.67% from $126.9 million recorded in Q2 2025.
- Utah Medical Products' 5-year Retained Earnings high stood at $139.0 million for Q1 2024, and its period low was $112.9 million during Q1 2021.
- For the 5-year period, Utah Medical Products' Retained Earnings averaged around $126.5 million, with its median value being $128.0 million (2025).
- Its Retained Earnings has fluctuated over the past 5 years, first soared by 1088.58% in 2023, then plummeted by 776.36% in 2025.
- Quarter analysis of 5 years shows Utah Medical Products' Retained Earnings stood at $115.3 million in 2021, then grew by 9.27% to $126.0 million in 2022, then increased by 9.79% to $138.3 million in 2023, then fell by 6.53% to $129.3 million in 2024, then decreased by 1.04% to $128.0 million in 2025.
- Its last three reported values are $128.0 million in Q3 2025, $126.9 million for Q2 2025, and $128.2 million during Q1 2025.